|
CIB Outperformance Drives Raised FY26 Guidance as Markets Revenue Surges 35%
FY2026
Q2
| Jul 15, 2026
|
|
Record Markets Revenue and IB Rebound Drive 10% Firmwide Revenue Growth
FY2026
Q1
| Apr 15, 2026
|
|
NII Guidance Lifted to ~$92B (ex-Markets) on CIB Momentum and Organic Capital Deployment
FY2025
Q2
| Oct 23, 2025
|
|
Investment Banking Rebound Fuels Q1 Results; NII Outlook Ticks Higher Amid Cautious Capital Stance
FY2024
Q1
| Oct 22, 2025
|
|
2024 NII ex-Markets Guided to ~$88B, Signaling Normalization After Record Full-Year Earnings
FY2023
Q4
| Oct 22, 2025
|
|
NII Outlook Lifted Again to ~$89B; Management Escalates Warnings on Basel III Capital Impact
FY2023
Q3
| Oct 22, 2025
|
|
NII Guidance Raised to $58B+ as Firm Pauses Buybacks to Bolster Capital Amid Macro Uncertainty
FY2022
Q2
| Oct 22, 2025
|
|
First Credit Reserve Build Since 2020 and Lower Capital Ratio Temper Raised NII Outlook
FY2022
Q1
| Oct 22, 2025
|